Impact of Fluid Restriction Policy in Reducing the Use of Red Cells in Cardiac Surgery

NCT00600704 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 192

Last updated 2011-06-07

Study results available
· View outcomes & findings →

Summary

The investigators' hypothesis is that restriction of circulating fluids in comparison to a liberal fluid administration policy would lead to a reduction of allogenic red blood cells exposure in patients undergoing cardiopulmonary bypass (CPB) for primary coronary artery bypass graft supported by reinfusion of washed shed blood from thoracic cavities.

Conditions

Interventions

PROCEDURE

Fluid Restriction Policy

Infusion of Hes 130/0.4 up to 500 ml until the beginning of Cardiopulmonary bypass

PROCEDURE

Free fluid infusion

Free fluid infusion unless Hb\< 6g/dl(allogenic blood use), until the beginning of Cardiopulmonary bypass

Sponsors & Collaborators

  • Larissa University Hospital

    lead OTHER

Principal Investigators

  • ATHINA KLEITSAKI, Dr · Larissa University Hospital

  • GEORGE VRETZAKIS, M.D. PhD · Cardiac Anesthesia Unit, Department of Anesthesiology, University Hospital of Larissa, Greece

  • KONSTANTINOS STAMOULIS, M.D. · Cardiac Anesthesia Unit, Department of Anesthesiology, University Hospital of Larissa, Greece

  • CHRISTOS DRAGOUMANIS, M.D. PhD · Cardiac Anesthesia Unit, Department of Anesthesiology, University Hospital of Larissa, Greece

  • VASILIOS TASOUDIS, M.D. · Cardiac Anesthesia Unit, Department of Anesthesiology, University Hospital of Larissa, Greece

  • KATERINA KYRIAKAKI, M.D. · Cardiac Anesthesia Unit, Department of Anesthesiology, University Hospital of Larissa, Greece

  • DEMETRIOS MIKROULIS, M.D. PhD · Department of Cardiothoracic Surgery, University Hospital of Larissa, Greece

  • ATHANASIOS GIANNOUKAS, MD MSc PhD · Department of Vascular Surgery, University Hospital of Larissa, Greece

  • NIKOLAOS TSILIMINGAS, M.D. PhD · Department of Cardiothoracic Surgery, University Hospital of Larissa, Greece

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-11-30
Primary Completion
2008-11-30
Completion
2011-03-31

Countries

  • Greece

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00600704 on ClinicalTrials.gov